EP2010499A4 - Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns - Google Patents

Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns

Info

Publication number
EP2010499A4
EP2010499A4 EP07718769A EP07718769A EP2010499A4 EP 2010499 A4 EP2010499 A4 EP 2010499A4 EP 07718769 A EP07718769 A EP 07718769A EP 07718769 A EP07718769 A EP 07718769A EP 2010499 A4 EP2010499 A4 EP 2010499A4
Authority
EP
European Patent Office
Prior art keywords
oxcarbazepine
microns
particle size
pharmaceutical compositions
median particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07718769A
Other languages
German (de)
French (fr)
Other versions
EP2010499A1 (en
Inventor
Brett Antony Mooney
Panagiotis Keramidas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alphapharm Pty Ltd
Original Assignee
Alphapharm Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006902079A external-priority patent/AU2006902079A0/en
Application filed by Alphapharm Pty Ltd filed Critical Alphapharm Pty Ltd
Publication of EP2010499A1 publication Critical patent/EP2010499A1/en
Publication of EP2010499A4 publication Critical patent/EP2010499A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP07718769A 2006-04-21 2007-04-20 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns Withdrawn EP2010499A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2006902079A AU2006902079A0 (en) 2006-04-21 Pharmaceutical compound and composition
PCT/AU2007/000522 WO2007121523A1 (en) 2006-04-21 2007-04-20 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns

Publications (2)

Publication Number Publication Date
EP2010499A1 EP2010499A1 (en) 2009-01-07
EP2010499A4 true EP2010499A4 (en) 2012-07-18

Family

ID=38624464

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07718769A Withdrawn EP2010499A4 (en) 2006-04-21 2007-04-20 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns

Country Status (3)

Country Link
EP (1) EP2010499A4 (en)
AU (1) AU2007242062A1 (en)
WO (1) WO2007121523A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540346A (en) * 2006-01-31 2008-11-20 テバ ファーマシューティカル インダストリーズ リミティド Pharmaceutical formulation of oxcarbazepine and preparation method thereof
MX364381B (en) * 2013-03-15 2019-04-25 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of oxcarbazepine.
WO2015063670A1 (en) * 2013-10-30 2015-05-07 Wockhardt Limited Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (en) * 1997-02-14 1998-08-20 Novartis Ag Oxacarbazepine film-coated tablets
WO2002094774A2 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
WO2007029093A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Pharmaceutical dosage forms of oxcarbazepine
WO2007053904A1 (en) * 2005-11-10 2007-05-18 Alphapharm Pty Ltd Process to control particle size
WO2008037044A1 (en) * 2006-09-27 2008-04-03 Medley S.A. Indústria Farmacêutica Oxcarbazepine-containing oral formulation and a process to obtain the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006046105A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
WO2007007182A2 (en) * 2005-07-08 2007-01-18 Aurobindo Pharma Limited Solid and liquid dosage forms of an antiepileptic agent

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (en) * 1997-02-14 1998-08-20 Novartis Ag Oxacarbazepine film-coated tablets
WO2002094774A2 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
WO2007029093A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Pharmaceutical dosage forms of oxcarbazepine
WO2007053904A1 (en) * 2005-11-10 2007-05-18 Alphapharm Pty Ltd Process to control particle size
WO2008037044A1 (en) * 2006-09-27 2008-04-03 Medley S.A. Indústria Farmacêutica Oxcarbazepine-containing oral formulation and a process to obtain the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007121523A1 *

Also Published As

Publication number Publication date
WO2007121523A1 (en) 2007-11-01
AU2007242062A1 (en) 2007-11-01
EP2010499A1 (en) 2009-01-07

Similar Documents

Publication Publication Date Title
IL247417A0 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
AU2014221210A1 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
ZA200900028B (en) Improvements relating to pharmaceutical compositions
IL195237A0 (en) Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same
GB0710369D0 (en) Improvements relating to perfume particles
HK1126975A1 (en) Pharmaceutical compositions with enhanced stability
IL195541A0 (en) Pharmaceutical compositions of memantine
EP2025337A4 (en) External pharmaceutical composition
EP2005959A4 (en) External pharmaceutical composition
PL2005958T3 (en) External pharmaceutical composition
EP2056835A4 (en) Pharmaceutical compositions and uses thereof
EP2104554A4 (en) Compositions of particles
EP2431038A4 (en) Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles
EP2179731A4 (en) Amino-acid-containing medicinal granular preparation highly easy to take
EP2070919A4 (en) Spiroquinone compound and pharmaceutical composition
IL193358A0 (en) Fluvastatin sodium pharmaceutical compositions
HK1156844A1 (en) Pharmaceutical composition 271 271
EP2010499A4 (en) Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
HK1165275A1 (en) Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition
IL198835A0 (en) Pharmaceutical compositions of memantine
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
EP2275112A4 (en) Antitumoral terpenoid pharmaceutical composition 'abisilin' exhibiting angiogenesis-inhibiting action
GB0716907D0 (en) Pharmaceutical powder compositions
AP2010005265A0 (en) Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid and uses thereof
EP2114404A4 (en) Pharmaceutical compound and composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20120615

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 223/22 20060101AFI20120611BHEP

Ipc: A61K 31/55 20060101ALI20120611BHEP

Ipc: A61P 25/08 20060101ALI20120611BHEP

Ipc: A61K 9/20 20060101ALI20120611BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130115